On Command Drug Delivery via Cell-Conveyed Phototherapeutics.

Published

Journal Article

Herein, the use of red blood cells (RBCs) as carriers of cytoplasmically interned phototherapeutic agents is described. Photolysis promotes drug release from the RBC carrier thereby providing the means to target specific diseased sites. This strategy is realized with a vitamin B12-taxane conjugate (B12-TAX), in which the drug is linked to the vitamin via a photolabile CoC bond. The conjugate is introduced into mouse RBCs (mRBCs) via a pore-forming/pore-resealing procedure and is cytoplasmically retained due to the membrane impermeability of B12. Photolysis separates the taxane from the B12 cytoplasmic anchor, enabling the drug to exit the RBC carrier. A covalently appended Cy5 antenna sensitizes the conjugate (Cy5-B12-TAX) to far red light, thereby circumventing the intense light absorbing properties of hemoglobin (350-600 nm). Microscopy and imaging flow cytometry reveal that Cy5-B12-TAX-loaded mRBCs act as drug carriers. Furthermore, intravital imaging of mice furnish a real time assessment of circulating phototherapeutic-loaded mRBCs as well as evidence of the targeted photorelease of the taxane upon photolysis. Histopathology confirms that drug release occurs in a well resolved spatiotemporal fashion. Finally, acoustic angiography is employed to assess the consequences of taxane release at the tumor site in Nu/Nu-tumor-bearing mice.

Full Text

Duke Authors

Cited Authors

  • Marvin, CM; Ding, S; White, RE; Orlova, N; Wang, Q; Zywot, EM; Vickerman, BM; Harr, L; Tarrant, TK; Dayton, PA; Lawrence, DS

Published Date

  • September 2019

Published In

Volume / Issue

  • 15 / 37

Start / End Page

  • e1901442 -

PubMed ID

  • 31353802

Pubmed Central ID

  • 31353802

Electronic International Standard Serial Number (EISSN)

  • 1613-6829

Digital Object Identifier (DOI)

  • 10.1002/smll.201901442

Language

  • eng

Conference Location

  • Germany